Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PerkinElmer Neonatal IVD Seizure Attributed To Poor Documentation

This article was originally published in The Gray Sheet

Executive Summary

Recent staff turnover at PerkinElmer's Norton, Ohio manufacturing site partly accounted for a failure to address QSR violations that prompted seizure of neonatal screening kits, according to the firm
Advertisement

Related Content

Neonatal Stand-Alone Screening Kit For Metabolic Disorders Cleared By FDA
Neonatal Stand-Alone Screening Kit For Metabolic Disorders Cleared By FDA
PerkinElmer
PerkinElmer
Advertisement
UsernamePublicRestriction

Register

MT019723

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel